Koyfin Home > Directory > Health Care > Aduro Biotech > Net Debt / (EBITDA-CAPEX)

Aduro Biotech Net Debt / (EBITDA-CAPEX) Chart (ADRO)

Aduro Biotech annual/quarterly Net Debt / (EBITDA-CAPEX) from 2013 to 2020.
  • Aduro Biotech Net Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $3m a 2.14% increase of 0m year over year
  • Aduro Biotech Net Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $3m a -7.96% decrease of 0m year over year
  • Aduro Biotech Annual Net Debt / (EBITDA-CAPEX) for 2019 was $2m a -23.28% decrease of -1m from 2018
  • Aduro Biotech Annual Net Debt / (EBITDA-CAPEX) for 2018 was $3m a -10.84% decrease of 0m from 2017
  • Aduro Biotech Annual Net Debt / (EBITDA-CAPEX) for 2017 was $3m a -19.50% decrease of -1m from 2016
Other Ratios Metrics:
  • Aduro Biotech Total Debt / Capital for the quarter ending September 09, 2014 was $4m
  • Aduro Biotech Other Liabilities for the quarter ending December 12, 2018 was $192m a 1.13% increase of 2m year over year
  • Aduro Biotech Total Debt / Equity for the quarter ending September 09, 2014 was $4m
View Chart On Koyfin

Quarterly ADRO Net Debt / (EBITDA-CAPEX) Data

06/2020$3m
03/2020$7m
12/2019$2m
09/2019$3m
06/2019$3m
03/2019$3m
12/2018$3m
09/2018$3m
06/2018$3m
03/2018$3m

Annual ADRO Net Debt / (EBITDA-CAPEX) Data

2019$2m
2018$3m
2017$3m
2016$4m
2015$30m
2014$6m
2013$0m
2012$0m